Cancer communications (London, England) · 2023
Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors.
Chen et al.
Photobiomodulation
- Journal
- Cancer communications (London, England)
- Year
- 2023
- Publication type
- Journal Article|Research Support, Non-U.S. Gov't